Methods for measuring temporary health states for cost-utility analyses

PharmacoEconomics

Volumn 27, Issue 9, 2009, Pages 713-723

  Wright, Davene R ^a   Wittenberg, Eve ^a,b   Swan, J Shannon ^a,c   Miksad, Rebecca A ^c,d   Prosser, Lisa A ^a,e,f  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRANDEIS UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e HARVARD PILGRIM HEALTH CARE   (United States)

^f UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITION; COST CONTROL; COST UTILITY ANALYSIS; HEALTH HAZARD; HEALTH STATUS; LIFESPAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; WELLBEING;

COSTS AND COST ANALYSIS; DELIVERY OF HEALTH CARE; HEALTH CARE COSTS; HEALTH STATUS; HUMANS; PATIENT SATISFACTION; QUALITY-ADJUSTED LIFE YEARS;

EID: 70349406572     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11317060-000000000-00000     Document Type: Review

References (53)

1. Prosser LA, Lieu TA. Comments on the Prosser et al. approach to value disease reduction in children. Pediatrics 2004 Nov; 114 (5): 1375-1376
2. Dolan P, Stalmeier P. The validity of time trade-off values in calculating QALYs: constant proportional time trade-off versus the proportional heuristic. J Health Econ 2003 May; 22 (3): 445-458
3. Bala M, Wood L, Zarkin G, et al. Are health states 'timeless'? Epidemiol 1999; 52 (11): 1047-1053
4. The cost-effectiveness analysis registry 2005 [online]. Available from URL: http://research.tufts-nemc.org/cear/default.aspx [Accessed 2008 Mar 1]
5. Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care pro-grammes. 3rd ed. New York: Oxford University Press, 2005
6. Pliskin JS, Shepard DS, Weinstein MC. Utility functions for life years and health status. Operations Res 1980 01; 28 (1): 206-224
7. Dolan P. Output measures and valuation in health. In: Drummond MF, McGuire A, editors. Economic evaluation in health care. New York: Oxford University Press, 2001: 46-67
8. Bleichrodt H, Johannesson M. The validity of QALYs: an experimental test of constant proportional tradeoff and utility independence. Med Decis Making 1997 Jan-Mar; 17 (1): 21-32
9. Bleichrodt H, Wakker PP, Johannesson M. Characterizing QALYs by risk neutrality. J Risk Uncertain 1997; 15 (2): 107-114
10. Wakker P, Stiggelbout A. Explaining distortions in utility elicitation through the rank-dependent model for risky choices. Med Decis Making 1995 Apr-Jun; 15 (2): 180-186
11. Bleichrodt H, Diecidue E, Quiggin J. Equity weights in the allocation of health care: the rank-dependent QALY model. J Health Econ 2004 Jan; 23 (1): 157-171
12. Lazaro A, Barberan R, Rubio E. Private and social time preferences for health and money: an empirical estimation. Health Econ 2001 Jun; 10 (4): 351-356
13. Johannesson M, Pliskin JS, Weinstein MC. A note on QA-LYs, time tradeoff, and discounting. Med Decis Making 1994 Apr-Jun; 14 (2): 188-193
14. Turner D, Wailoo A, Nicholson K, et al. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Leicester: University of Leicester and University of Sheffield, 2002 Apr 29
15. Swan JS, Fryback DG, Lawrence WF, et al. A time-tradeoff method for cost-effectiveness models applied to radiology. Med Decis Making 2000 Jan-Mar; 20 (1): 79-88
16. Yin D, Baum RA, Carpenter JP, et al. Cost-effectiveness of MR angiography in cases of limb-threatening peripheral vascular disease. Radiology 1995 Mar; 194 (3): 757-764
17. Griffiths TL, Phillips CJ, Davies S, et al. Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax 2001 Oct; 56 (10): 779-784
18. Lavernia CJ, Guzman JF, Gachupin-Garcia A. Cost effectiveness and quality of life in knee arthroplasty. Clin Or-thop Relat Res 1997 Dec; 345: 134-139
19. Lieu TA, Ortega-Sanchez I, Ray GT, et al. Community and patient values for preventing Herpes zoster. Pharmacoe-conomics 2008; 26 (3): 235-249
20. Swan JS, Lawrence WF, Roy J. Process utility in breast biopsy. Med Decis Making 2006 Jul-Aug; 26 (4): 347-359
21. Dominitz JA, Provenzale D. Patient preferences and quality of life associated with colorectal cancer screening. Am J Gastroenterol 1997 Dec; 92 (12): 2171-2178 The case of the standard gamble method. J Clin
22. Badia X, Monserrat S, Roset M, et al. Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off. Qual Life Res 1999 Jun; 8 (4): 303-310
23. Jansen SJ, Stiggelbout AM, Wakker PP, et al. lities for cancer treatments: a study of the chained procedure for the standard gamble and time tradeoff. Med Decis Making 1998 Oct-Dec; 18 (4): 391-399
24. Oldridge N, Furlong W, Feeny D, et al. Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction. Am J Cardiol 1993 Jul 15; 72 (2): 154-161
25. Pace KT, Dyer SJ, Phan V, et al. Laparoscopic v open donor nephrectomy: a cost-utility analysis of the initial experience at a tertiary-care center. J Endourol 2002 Sep; 16 (7): 495-508
26. Lee GM, Salomon JA, LeBaron CW, et al. Health-state valuations for pertussis: methods for valuing short-term health states. Health Qual Life Outcomes 2005; 3: 17
27. Prosser LA, Ray GT, ingness to pay for health states prevented by pneumococcal conjugate vaccine. Pediatrics 2004 Feb; 113 (2): 283-290
28. Beutels P, Viney RC. Comments on the Prosser et al. approach to value disease reduction in children [author reply]. Pediatrics 2004 Nov; 114 (5): 1375-1376
29. Prosser LA, Ladapo JA, Rusinak D, et al. Parental tolerance for false-positive newborn screening results. Arch Pediatr Adolesc Med 2008 Sep; 162 (9): 870-876
30. Swan JS, Sainfort F, Lawrence WF, et al. Process utility for imaging in cerebrovascular disease. Acad Radiol 2003 Mar; 10 (3): 266-274
31. Cook J, Richardson J, Street A. A cost utility analysis of treatment options for gallstone disease: methodological issues and results. Health Econ 1994 May-Jun; 3 (3): 157-168
32. Jansen SJ, Stiggelbout AM, Wakker PP, et al. Unstable preferences: a shift in valuation or an effect of the elicitation procedure? Med Decis Making 2000 Jan-Mar; 20 (1): 62-71
33. Locadia M, Stalmeier PF, Oort FJ, et al. A comparison of 3 valuation methods for temporary health states in patients treated with oral anticoagulants. Med Decis Making 2004 Nov-Dec; 24 (6): 625-633
34. McNamee P, Glendinning S, Shenfine J, et al. Chained time trade-off and standard gamble methods: applications in oesophageal cancer. Eur J Health Econ 2004 Feb; 5 (1): 81-86
35. Gage BF, Cardinalli AB, Owens DK. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch Intern Med 1996 Sep 9; 156 (16): 1829-1836
36. Merlino LA, Bagchi I, Taylor TN, et al. Preference for fractures and other glucocorticoid-associated adverse effects among rheumatoid arthritis patients. Med Decis Making 2001 Mar-Apr; 21 (2): 122-132
37. Tosteson AN, Kneeland TS, Nease RF, et al. Automated current health time-trade-off assessments in health. Value Health 2002 Mar-Apr; 5 (2): 98-105
38. Tosteson AN, Kneeland TS, Nease R. Feasibility of automated utility assessment in a phase III clinical trails: U-Titer and a raloxifene osteoporosis prevention trial. Med Decis Making 1995; 15: 412-436
39. Keeney R, Raiffa H. Decisions with multiple objectives: preferences and value tradeoffs. New York: Cambridge University Press, 1993
40. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ 1986; 5: 1-30
41. Kaplan RM, Bush JW, Berry CC. Health status: types of validity and the index of well-being. Health Serv Res 1976 Winter; 11 (4): 478-507
42. Kaplan RM, Anderson JP, Wu AW, et al. The Quality of Well-Being scale: applications in AIDS, cystic fibrosis, and arthritis. Med Care 1989 Mar; 27 (3 Suppl.): S27-43
43. Anderson JP, Kaplan RM, Berry CC, et al. Interday reliability of function assessment for a health status measure: the Quality of Well-Being scale. Med Care 1989 Nov; 27 (11): 1076-1083
44. Kaplan RM, Anderson JP. An integrated approach to quality of life assessment: the general health policy model. In: Spilker B, editor. Quality of life in clinical studies. New York: Raven Press, 1990: 131-149
45. Torrance GW, Feeny DH, Furlong WJ, et al. Multiattribute utility function for a comprehensive health status classification system: Health Utilities Index Mark 2. Med Care 1996 Jul; 34 (7): 702-722
46. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 2005 Mar; 43 (3): 203-220
47. Kaplan RM, Anderson JP, Ganiants TG. The Quality of Well-Being scale: rationale for a single quality of life index. In: Walker SR, Rosser RM, editors. Quality of life assessment: key issues in the 1990s. 2nd ed. New York: Springer-Verlag, 1999
48. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res 1972 Summer; 7 (2): 118-133
49. van Nooten F, Brouwer W. The influence of subjective expectations about length and quality of life on time trade-off answers. Health Econ 2004 Aug; 13 (8): 819-823
50. Cullen J, Schwartz MD, Lawrence WF, et al. Short-term impact of cancer prevention and screening activities on quality of life. J Clin Oncol 2004 Mar 1; 22 (5): 943-952
51. Rutten-van Molken MP. Methodological issues of patient utility measurement: experience from two clinical trials. Med Care 1995; 33 (9): 922-937
52. O'Connor on patients' Epidemiol 1989; 42 (2): 119-126
53. Bennett KJ, Torrance GW. Measuring health state prefer-women's ences and utilities: rating scale, time trade-off, and standard gamble techniques. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia (PA): Lippincott-Raven, 1996: 253-265